iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Bought by Avantax Planning Partners Inc.

Avantax Planning Partners Inc. lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.0% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,649 shares of the financial services provider’s stock after purchasing an additional 78 shares during the quarter. Avantax Planning Partners Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $270,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Eagle Bay Advisors LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the second quarter worth $28,000. First Horizon Corp increased its holdings in iShares Nasdaq Biotechnology ETF by 166.7% in the second quarter. First Horizon Corp now owns 192 shares of the financial services provider’s stock valued at $31,000 after buying an additional 120 shares in the last quarter. Concord Wealth Partners increased its holdings in iShares Nasdaq Biotechnology ETF by 522.2% in the first quarter. Concord Wealth Partners now owns 224 shares of the financial services provider’s stock valued at $34,000 after buying an additional 188 shares in the last quarter. Disciplined Investments LLC increased its holdings in iShares Nasdaq Biotechnology ETF by 108.2% in the second quarter. Disciplined Investments LLC now owns 254 shares of the financial services provider’s stock valued at $42,000 after buying an additional 132 shares in the last quarter. Finally, Running Point Capital Advisors LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the first quarter valued at $39,000. 71.40% of the stock is owned by hedge funds and other institutional investors.

IBB opened at $169.93 on Wednesday. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $128.23 and a fifty-two week high of $177.37. The company has a fifty day moving average of $168.51 and a two-hundred day moving average of $159.13.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is a put option?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.